Loading...
Precipio, Inc.
PRPO•NASDAQ
Healthcare
Medical - Diagnostics & Research
$14.70
$0.49(3.45%)
Precipio, Inc. (PRPO) Financial Performance & Income Statement Overview
Review Precipio, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
5.05%
↑ 5.05%
Operating Income Growth
44.67%
↑ 44.67%
Net Income Growth
26.70%
↑ 26.70%
Operating Cash Flow Growth
112.33%
↑ 112.33%
Operating Margin
-15.50%
↓ 15.50%
Gross Margin
43.82%
↑ 43.82%
Net Profit Margin
-15.99%
↓ 15.99%
ROE
-25.87%
↓ 25.87%
ROIC
-22.31%
↓ 22.31%
Precipio, Inc. (PRPO) Income Statement & Financial Overview
Review Precipio, Inc.'s (PRPO) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $4.26M | $5.45M | $5.21M | $4.44M |
| Cost of Revenue | $2.12M | $2.80M | $2.93M | $3.02M |
| Gross Profit | $2.14M | $2.65M | $2.28M | $1.42M |
| Gross Profit Ratio | $0.50 | $0.49 | $0.44 | $0.32 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $2.65M | $0.00 | $2.63M |
| Operating Expenses | $3.00M | $2.98M | $2.87M | $2.63M |
| Total Costs & Expenses | $5.12M | $5.79M | $5.81M | $5.65M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | -$25000.00 | $29000.00 | $29000.00 | $11000.00 |
| Depreciation & Amortization | $0.00 | $382000.00 | $381000.00 | $355000.00 |
| EBITDA | -$859000.00 | $46000.00 | -$216000.00 | -$854000.00 |
| EBITDA Ratio | -$0.20 | $0.008 | -$0.04 | -$0.19 |
| Operating Income | -$859000.00 | -$336000.00 | -$597000.00 | -$1.21M |
| Operating Income Ratio | -$0.20 | -$0.06 | -$0.11 | -$0.27 |
| Other Income/Expenses (Net) | -$25000.00 | -$29000.00 | -$29000.00 | -$11000.00 |
| Income Before Tax | -$884000.00 | -$365000.00 | -$626000.00 | -$1.22M |
| Income Before Tax Ratio | -$0.21 | -$0.07 | -$0.12 | -$0.27 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$884000.00 | -$365000.00 | -$626000.00 | -$1.22M |
| Net Income Ratio | -$0.21 | -$0.07 | -$0.12 | -$0.27 |
| EPS | -$0.59 | -$0.25 | -$0.42 | -$0.83 |
| Diluted EPS | -$0.59 | -$0.25 | -$0.42 | -$0.83 |
| Weighted Avg Shares Outstanding | $1.50M | $1.47M | $1.48M | $1.46M |
| Weighted Avg Shares Outstanding (Diluted) | $1.50M | $1.47M | $1.48M | $1.46M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan